Sintetica established its subsidiary Sintetica US
Sintetica, a Swiss pharmaceutical company headquartered in Mendrisio and specialized in the production of injectable medicines in the field of pain therapy, takes another important and significant step in its 100-year growth strategy.
On July 14 the Corporate was strengthened by a new entity Sintetica US which will be headquartered in Princeton, New Jersey. Sintetica US, headed by President Frank Mullery, will manage the US market directly, establishing strategic partnerships that will help Sintetica continue on a solid path of continued growth.
“I am very proud of this further important step in the growth of our company, which is increasingly establishing itself on international markets for the quality of its products and the reliability of its services. I would like to thank the many people involved (employees, stakeholders and KOLS) who make our ongoing success story possible every day.”
Nicola Caronzolo - CEO
"I am honored to have the opportunity to lead the Sintetica US team. It is a very exciting time for our company. Sintetica is uniquely positioned with a strong core business, best in class research and development, high quality Swiss manufacturing, and a valuable pipeline. I look forward to working with Nicola, our board, the management team and all Sintetica employees to continue to grow the business and bring innovative products to the US customers and patients."
Frank Mullery | President US
Contacts
